What is iHear Medical?
iHear Medical operates at the intersection of consumer health and medical technology, focusing on the development of high-quality, accessible hearing solutions. By prioritizing the needs of seniors and the hearing-impaired, the company effectively bridges the gap between clinical-grade devices and consumer-friendly retail accessibility. Their business model emphasizes the removal of traditional barriers to entry, such as prescription requirements, thereby empowering individuals to manage their wellness through a streamlined, digital-first approach. This strategic positioning allows iHear Medical to capture significant market share in the rapidly evolving over-the-counter health and wellness landscape.
How much funding has iHear Medical raised?
iHear Medical has raised a total of $9.6M across 5 funding rounds:
Series A
$475K
Series B
$1.8M
Series C
$5M
Debt
$2.3M
Debt
$70K
Series A (2010): $475K with participation from Aphelion Capital
Series B (2012): $1.8M, investors not publicly disclosed
Series C (2014): $5M supported by Aphelion Capital, Ameritas Holding Company, and Lighthouse Capital
Debt (2017): $2.3M featuring Ameritas Life Insurance Corp and Aphelion Capital
Debt (2021): $70K backed by PPP
Key Investors in iHear Medical
Aphelion Capital
Aphelion Capital is a specialized medical technology investment firm that focuses on long-term partnerships with companies that improve care quality while reducing systemic healthcare costs.
Ameritas Life Insurance Corp
Ameritas is a mutual insurance company providing a comprehensive suite of life, dental, and disability insurance products alongside diversified financial services.
Lighthouse Capital
Lighthouse Capital is a strategic investment partner focused on supporting high-growth enterprises through disciplined capital allocation and operational guidance.
What's next for iHear Medical?
With the infusion of this latest capital, iHear Medical is well-positioned to accelerate its operational scaling and product innovation roadmap. The company's strategic focus will likely shift toward enhancing its distribution infrastructure and expanding its portfolio of wellness products to meet the growing demand for non-prescription health aids. By maintaining its commitment to cost-effective, high-quality care, iHear Medical is poised to capitalize on the broader shift toward decentralized healthcare, ensuring long-term value creation for its stakeholders and improved health outcomes for its diverse user base.
See full iHear Medical company page
